In re Arrowhead Research Corp., Securities Litigation

  1. March 29, 2016

    Arrowhead Ducks Investor Suit Over Hep B Drug Trial

    After tentatively green-lighting investors' claims earlier this year that Arrowhead Research Corp. overstated Hepatitis B vaccine trial results, a California federal judge tossed the proposed class action on Tuesday, saying the suit was too thin on specifics.

  2. January 05, 2016

    Arrowhead Can't Ditch Investor Suit Over Hep B Drug Trial

    A California judge on Tuesday tentatively refused to dismiss a putative shareholder class action against Arrowhead Research Corp. over claims that the biopharmaceuticals maker misled investors about the progress of human trials for its hepatitis B vaccine, inflating its stock.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!